When the breakthrough cancer drug Gleevec made headlines, Yale Cancer Center Director Vincent T. DeVita Jr., M.D., HS ’66, was on hand (and online) to share his perspective with Web surfers at discoveryhealth.com. When the threat of bioterrorism put the nation on edge, infectious disease expert Andre N. Sofair, M.D., M.P.H. ’97, HS ’90, weighed in with “10 Things You Need to Know About Anthrax.” Both pieces grew from a new partnership between Yale and the Discovery Health Channel, which will draw on expertise from throughout the medical school. Faculty will also contribute to four, hour-long television programs and to three online columns: “Family Matters,” “Cutting Edge Medicine” and “Views on Health News.” The first cable special, about ADHD, will air later this year.